C22-Ceramide
C22-Ceramide (Cer d18:1/22:0) is an endogenous bioactive sphingolipid. C22-Ceramide reduces the propensity of C16-ceramide channel formation in isolated rat liver mitochondria and in liposomes[1].
Product Specifications
CAS Number
27888-44-4
Product Name Alternative
N-Behenoyl-D-erythro-sphingosine; Cer d18:1/22:0
UNSPSC
12352211
Target
Liposome
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/c22-ceramide.html
Purity
98.0
Solubility
DMF : 0.33 mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCCCCCCCCCCCCCCCCCCCCC(N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC)=O
Molecular Formula
C40H79NO3
Molecular Weight
622.06
References & Citations
[1]Stiban J, et al. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis. Biochim Biophys Acta. 2015 Feb;1848 (2) :561-7.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY423531 100 µg
ARHGAP17 (NM_001006634) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC940988-500 1x 500 µL
CD54 (W-CAM-1; same as Wehi-CAM-1 or 1H4), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401899-100 1x 100 µL
Parathyroid Hormone (PTH) (N-Terminal) (rPTH/911), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details